Recent Finacing
Recent Raise
Spinifex Pharmaceuticals is a biopharmaceutical company developing EMA401, an oral AT2 receptor antagonist for neuropathic and inflammatory pain, advancing Phase 2 trials targeting peripheral neuropathies without CNS side effects.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors